Andre Uden
Analyst, Research Capital
Replay available
Medexus Pharmaceuticals Inc. (MDP) Q1 2027 Earnings Call
Medexus Pharmaceuticals Inc. (TSX: MDP) Q1 2027 earnings conference call, held 2026-08-11. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Ken d'Entremont
Chief Executive Officer
Chris Pugh
Analyst, Canaccord Genuity
Scott Henry
Analyst, AGP
Brendon Buschman
Chief Financial Officer
Michael Freeman
Analyst, Raymond James
Victoria Rutherford
Investor Relations
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Medexus Pharmaceuticals Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.536 Greetings. Welcome to the Medexus Pharmaceuticals first quarter 2027 00:00:05.536 -- 00:00:11.020 conference call. At this time, all participants are in a listen-only mode. 00:00:11.020 -- 00:00:15.204 A question and answer session will follow the formal presentation. 00:00:15.204 -- 00:00:19.808 If anyone should require operator assistance during the conference, please press star 00:00:19.808 -- 00:00:24.452 zero on your telephone keypad. Please note this conference is being recorded. 00:00:24.452 -- 00:00:30.190 I will now turn the conference over to your host, Victoria Rutherford, Investor Relations, 00:00:30.190 -- 00:00:32.531 you may begin. 00:00:33.772 -- 00:00:39.294 Thank you, and good morning, everyone. Welcome to the Medexus Pharmaceuticals first fiscal 00:00:39.294 -- 00:00:44.355 quarter 2027 earnings call. On the call this morning are Ken d'Entremont, Chief 00:00:44.355 -- 00:00:47.877 Executive Officer, and Brendon Buschman, Chief Financial Officer. 00:00:47.877 -- 00:00:51.538 If you have any questions after the conference call or would like further information 00:00:51.538 -- 00:00:56.479 about the company, please contact Adelaide Capital at 480-625-5772. 00:00:58.273 -- 00:01:02.494 I would like to remind everyone that this discussion will include forward-looking information 00:01:02.494 -- 00:01:07.096 as defined in Canadian securities laws that is based on certain assumptions that Medexis 00:01:07.096 -- 00:01:12.198 believes to be reasonable in the circumstances but is subject to risks and 00:01:12.198 -- 00:01:17.339 uncertainties. Actual results may differ materially from historical results or 00:01:17.339 -- 00:01:20.540 results anticipated by the forward-looking information. 00:01:20.540 -- 00:01:27.065 In ...